首页> 外文期刊>International journal of biological sciences >Obstructive sleep apnea syndrome promotes the progression of aortic dissection via a ROS- HIF-1α-MMPs associated pathway
【24h】

Obstructive sleep apnea syndrome promotes the progression of aortic dissection via a ROS- HIF-1α-MMPs associated pathway

机译:阻塞性睡眠呼吸暂停综合征促进通过ROS-HIF-1α-MMP相关的途径促进主动脉夹层的进展

获取原文
获取外文期刊封面目录资料

摘要

Aims: Obstructive sleep apnea syndrome (OSAS) has been increasingly recognized as an independent risk factor for aortic dissection (AD) and it is strongly associated with the extent of intermittent hypoxia and re-oxygenation (IH). This study aimed to clarify role of ROS- HIF-1α-MMPs pathway in the pathogenesis of AD and whether the HIF-1α inhibitor attenuates AD formation. Methods and results: 8-week-old male ApoE-/- mice were given β-aminopropionitrile at a concentration of 0.1 % for 3 weeks and infused via osmotic mini pumps with either saline or 2,500 ng/min/kg angiotensin II (Ang II) for 2 weeks. To mimic the OSAS, one group was exposed to IH, which consisted of alternating cycles of 20.9% O2/8% O2 FiO2 (30 episodes per hour) with 20 s at the nadir FiO2 during the 12-h light phase, 2 weeks before Ang II infusion. After Ang II infusion, we assessed remodeling in the aorta by echocardiography, histological and immunohistochemical analysis. IH treatment resulted in significant enlargement of the luminal area, destruction of the media, marked thickening of the adventitia, higher incidence of AD formation and lower survival rate in compared with the Ang II only group. Moreover, IH exposure markedly increased the aortic ROS production and subsequent HIF-1α expression, which in turn promoted the expressions of VEGF, MMP2 and MMP9 and finally leading to the progression of AD. Besides, in vitro study confirmed that IH induced HIF-1α expression plays an important role in the induction of MMPs and that is regulated by the PI3K/AKT/FRAP pathway. Intriguingly, a selective HIF-1α inhibitor KC7F2 could significantly ameliorate IH exposure induced aforementioned deleterious effects in vitro and in vivo.Conclusion: OSAS induced IH can promote the occurrence and progression of AD via a ROS- HIF-1α-MMPs associated pathway. The selective HIF-1α inhibitor KC7F2 could be a novel therapeutic agent for AD patient with OSAS.? The author(s).
机译:目的:阻塞性睡眠呼吸暂停综合征(OSAs)越来越被认为是主动脉夹层(Ad)的独立危险因素,它与间歇性缺氧和重新氧合(IH)强烈相关。本研究旨在阐明ROS-HIF-1α-MMPS途径在AD发病机制中的作用以及HIF-1α抑制剂是否衰减广告形成。方法和结果:8周龄雄性涂层 - / - 小鼠浓度为0.1%的β-氨基丙腈3周,通过渗透迷你泵用盐水或2,500ng / min / kg血管紧张素II(Ang II ) 2周。为了模仿OSA,将一组暴露于IH,其在12-H光相的12小时内将20.9%O 2/8%O 2 FiO2(每小时30发发发作)组成的交替循环组成。 Ang II输液。 Ang II输注后,我们通过超声心动图,组织学和免疫组化分析评估主动脉的重塑。 IH治疗导致腔面积显着扩大,培养基的破坏,显着增厚的外膜增厚,与ANG II只有群体相比,较高的AD形成发病率和降低的存活率。此外,IH暴露率显着增加了主动脉ROS生产和随后的HIF-1α表达,这反过来促进了VEGF,MMP2和MMP9的表达,最终导致广告的进展。此外,体外研究证实,IH诱导的HIF-1α表达在诱导MMPS中起重要作用,并且由PI3K / AKT / FRAP途径调节。有趣的是,一种选择性HIF-1α抑制剂KC7F2可以显着改善IH暴露在体外和体内诱导上述有害作用。结论:OSAS诱导的IH可以通过ROS-HIF-1α-MMPS相关途径促进AD的发生和进展。选择性HIF-1α抑制剂KC7F2可以是具有OSAS的AD患者的新型治疗剂。作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号